ProfileGDS5822 / ILMN_2635437
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 74% 78% 76% 74% 79% 78% 76% 75% 72% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 172.174
GSM1276600PDAC Late Ablation Control 2117.678
GSM1276601PDAC Late Ablation Control 3128.976
GSM1276602PDAC Late Ablation 170.474
GSM1276603PDAC Late Ablation 2143.679
GSM1276604PDAC Late Ablation 3129.778
GSM1303940PDAC Late Ablation_anti-CTLA4 182.376
GSM1303941PDAC Late Ablation_anti-CTLA4 2106.275
GSM1303942PDAC Late Ablation_anti-CTLA4 379.972